Navigation Links
5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
Date:7/6/2009

ng and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

Contact: Carrie Melia - sanofi-aventis, +1-908-981-6486, carrie.melia@sanofi-aventis.com

US.GLA.09.07.021


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
2. Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
10. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Serving a region of ... Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... therapy capabilities with the acquisition of an Elekta Versa HD™ ... Versa HD offers clinicians the versatility to deliver conventional therapies ... while also enabling treatment of highly complex cancers that require ...
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)... 2013  Boston Scientific Corporation (NYSE: BSX ... Scientific Program May 21-24 in Paris ... particularly rich and diversified set of data this year ... M.D., global chief medical officer, Boston Scientific.  "The primary ... the NG PROMUS trial, which evaluated our Promus PREMIER ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... Acuo Technologies®, a market leading provider of ... for archiving, collaboration and migration services, is pleased ... of its market leading Vendor Neutral Archive software ... cloud-enablement, workflow services, and improved performance and scalability. ...
... Data Group,s (IDG) Computerworld announces Kaiser ... officer, care delivery, and Mike Brady, senior vice ... IT Leader honorees. This year,s Premier 100 spotlights ... sides of companies for their exceptional technology leadership, ...
Cached Medicine Technology:Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release 2Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100 2Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100 3Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100 4
(Date:5/17/2013)... Lake Arrowhead, CA (PRWEB) May 17, 2013 ... without extra health complications, but for diabetics, treatment is ... diabetics involves additional medical care to monitor blood sugar ... an addicted diabetic properly, a drug rehab for ... the unique dietary and nutritional needs of the diabetic, ...
(Date:5/17/2013)... sleep on mood, memory and learning was given ... Intel International Science and Engineering Fair (ISEF)the world,s ... awards are coordinated by the National Institute on ... of Health, and Friends of NIDA, a coalition ... Science Awards were presented at a ceremony Thursday ...
(Date:5/17/2013)... (HealthDay News) -- Too few obstetrics-gynecology residents in the ... lead to care issues for the rapidly growing number ... Researchers surveyed 510 ob/gyn residents and found that fewer ... menopause medicine, even though seven in 10 would like ... of fourth-year residents -- those soon to complete their ...
(Date:5/17/2013)... Working with lab mice models of multiple sclerosis (MS), ... for the design of drugs that could be safer ... , The findings of the research study, published ... could have therapeutic applications for MS as well ... loss of white matter, which is the brain tissue ...
(Date:5/17/2013)... The IUD safety advocates at DrugRisks.com are announcing ... the vaginal ring contraceptive NuvaRing. A recent report from ... blood clots from the devices has risen*. ... patients using popular prescription devices by providing the latest ... out if others are experiencing similar side effects and ...
Breaking Medicine News(10 mins):Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4Health News:Is Menopause Overlooked in U.S. Medical Schools? 2Health News:Study identifies new approach to improving treatment for MS and other conditions 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
... the NHS proposal to allow nurses to perform routine, ... as being equivalent to entrusting airhostesses // with the ... Medical Association (BMA) has been urged to alert the ... operations on patients. More than 130 doctors have indeed ...
... by the American Medical Association has left its readers tipsy with ... ,A survey of 644 female college students has revealed that breaking ... having fun in life. Three out of four women seem to ... drinking meant bingeing on booze, getting them all sick and drunk. ...
... is under pressure as it is asked to improve its ... who has had deep// ties with the company has her ... of directors for six years. Hillary Clinton said that her ... ,But in recent months, as the company has ...
... the Norfolk and Norwich University Hospital have been given the ... to women who test positive for her-2 gene. ... the therapeutic advisory groups, and the primary care trusts have ... the N&N. "About one in five women with breast cancer ...
... that British Asians are at least 50 percent more likely ... European origin. One in five has also developed type 2 ... in the UK. ,Of immediate concern are the ... blood pressure amongst South East Asians in the UK, said ...
... huge study involving 38 populations across 21 countries, reserachers have ... dropping.// ,"Blood pressure did not go down in ... of them," said Prof Tunstall-Pedoe, who led the World Health ... change was not great, but it did appear to have ...
Cached Medicine News:Health News:Doctors Protest Against Allowing Nurses To Perform Minor Surgeries 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: